Bristol-Myers Squibb Company to Keep a Seattle Presence; to Preserve About 275 ZymoGenetics, Inc. Jobs

Published: Jan 26, 2011

Seattle Times -- Bristol-Myers Squibb, which bought Seattle drugmaker ZymoGenetics last year, plans to keep a long-term presence in Seattle's South Lake Union district, a spokeswoman said late Tuesday.

Back to news